GWS
LLY icon

Greykasell Wealth Strategies’s Eli Lilly LLY Stock Holding History

Greykasell Wealth Strategies’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$350K Buy
381
+75
+25% +$76K 0.14% 112
2025
Q4 		$329K Hold
306
– – 0.13% 114
2025
Q3 		$233K Sell
306
-45
-13% -$33.5K 0.1% 128
2025
Q2 		$274K Sell
351
-47
-12% -$36.5K 0.13% 114
2025
Q1 		$329K Sell
398
-13
-3% -$10.8K 0.18% 99
2024
Q4 		$317K Buy
+411
New +$340K 0.18% 102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Greykasell Wealth Strategies's LLY Position: Q1 2026 in Review

Greykasell Wealth Strategies increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $76K and bringing the position to 381 shares worth $350K. The position accounts for 0.14% of the portfolio, ranked #112.

Greykasell Wealth Strategies first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Greykasell Wealth Strategies held 381 shares of Eli Lilly worth $350K as of Q1 2026.
  • Greykasell Wealth Strategies bought 75 Eli Lilly shares in Q1 2026, an estimated $76K.
  • Eli Lilly made up 0.14% of Greykasell Wealth Strategies's portfolio in Q1 2026, its #112 holding.
  • Greykasell Wealth Strategies first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Greykasell Wealth Strategies's 13F filing for Q1 2026, filed 7 May 2026.